Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
HUTCHMED Receives Approval for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Treatment
Tuesday, July 01, 2025HUTCHMED has received approval from the China National Medical Products Administration NMPA for the combination therapy of ORPATHYS savolitinib and TAGRISSO osimertinib
Takeda Receives Approval for GAMMAGARD LIQUID ERC, a Low-IgA Immunoglobulin Therapy
Tuesday, July 01, 2025Takeda has announced that the US Food and Drug Administration FDA has approved GAMMAGARD LIQUID ERC immune globulin infusion human for use in patients aged two years and above with primary immunodeficiency PI
Rocket Pharmaceuticals Receives FDA Clearance to Begin Human Trials of Gene Therapy for BAG3-associated Dilated Cardiomyopathy
Tuesday, July 01, 2025Rocket Pharmaceuticals has announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for RPA a gene therapy candidate for the treatment of BAGassociated Dilated Cardiomyopathy BAGDCM
Sobi Receives Approval for Gamifant® as Treatment for Macrophage Activation Syndrome in Still’s Disease
Monday, June 30, 2025Sobi has announced that the US Food and Drug Administration FDA has approved Gamifant emapalumablzsg as the first treatment for adults and children including newborns with macrophage activation syndrome MAS
Mabwell and Qilu Pharmaceutical Collaborate on Novel Injection for Chemotherapy-Induced Neutropenia
Monday, June 30, 2025Mabwell has signed a licensing agreement with Qilu Pharmaceutical for the development and commercialisation of Albipagrastim alfa for Injection RD code MW
ProFound Therapeutics and Novartis Partner to Develop Cardiovascular Treatments
Friday, June 27, 2025ProFound Therapeutics has entered into a fouryear strategic collaboration with Novartis to discover and develop new treatments for cardiovascular diseaseThe partnership brings together ProFounds expertise in protein discovery with Novartis longstandi...
KalVista Partners with Pendopharm to Commercialise Sebetralstat for Hereditary Angioedema in Canada
Friday, June 27, 2025KalVista Pharmaceuticals has entered into a licensing agreement with Pendopharm to support the commercialisation of its oral hereditary angioedema HAE treatment sebetralstat in Canada
Kymera Therapeutics and Sanofi Advance KT-485 into Clinical Development for Immune Diseases
Thursday, June 26, 2025Kymera Therapeutics has announced an update regarding its partnership with Sanofi on the IRAK programme KT is designed to treat immunoinflammatory diseases where significant unmet need remains IRAK plays a key role in regulating innate immunity and i...
Gilead Sciences and Kymera Therapeutics Partner to Develop Novel Oral CDK2 Degraders for Cancer Treatment
Thursday, June 26, 2025Gilead Sciences and Kymera Therapeutics have entered into an exclusive option and license agreement focused on advancing a new molecular glue degrader MGD programme targeting cyclindependent kinase CDK
Precision BioSciences Receives FDA Rare Paediatric Disease Designation for Duchenne Muscular Dystrophy Treatment
Thursday, June 26, 2025Precision BioSciences has been granted Rare Paediatric Disease Designation by the US Food and Drug Administration FDA for its investigational therapy PBGENEDMD aimed at treating Duchenne muscular dystrophy DMD
